Sanofi - ADR (SNY): Price and Financial Metrics

Sanofi - ADR (SNY): $46.72

0.03 (-0.06%)

POWR Rating

Component Grades








SNY Price/Volume Stats

Current price $46.72 52-week high $57.82
Prev. close $46.75 52-week low $42.63
Day low $46.28 Volume 1,162,260
Day high $46.86 Avg. volume 1,738,458
50-day MA $49.82 Dividend yield 2.93%
200-day MA $51.91 Market Cap 118.18B

SNY Stock Price Chart Interactive Chart >

Sanofi - ADR (SNY) Company Bio

Sanofi researches, develops, manufactures, and markets various therapeutic solutions. The company operates in three segments: Pharmaceuticals, Vaccines, and Animal Health. The company was founded in 1973 and is based in Paris, France.

SNY Latest News Stream

Event/Time News Detail
Loading, please wait...

SNY Latest Social Stream

Loading social stream, please wait...

View Full SNY Social Stream

Latest SNY News From Around the Web

Below are the latest news stories about SANOFI that investors may wish to consider to help them evaluate SNY as an investment opportunity.

Sanofi: Information concerning the total number of voting rights and shares - October 2023

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,529,036,828 €Registered office : 46, avenue de la Grande Armée - 75017 Paris - FranceRegistered at the Paris Commercial and Companies Regi

Yahoo | November 23, 2023

A Golden Age of Vaccines Is Here. What It Means for You.

Pharmaceutical companies are currently developing vaccines for a range of purposes, from preventing disease to treating cancers.

Yahoo | November 21, 2023

20 Most Valuable Healthcare Companies in the World

In this article, we will look into the 20 most valuable healthcare companies in the world. If you want to skip our detailed analysis, you can go directly to the 5 Most Valuable Healthcare Companies in the World. Healthcare Services Industry: A Market Analysis According to a report by Verified Market Research, the global healthcare […]

Yahoo | November 20, 2023

CORRECTED-UPDATE 2-CDC expedites release of 77,000 additional doses of Sanofi-AstraZeneca's RSV drug

The U.S. Centers for Disease Control and Prevention said on Thursday it has expedited the release of more than 77,000 additional doses of Sanofi and AstraZeneca's respiratory syncytial virus (RSV) drug Beyfortus. The additional doses, which the CDC said will be distributed immediately to physicians and hospitals, will help improve the availability of the drug at a time when a surge in cases of the disease is outpacing supply.

Yahoo | November 16, 2023

Sanofi Taps Adviser for OTC Spinoff as Buyout Firms Circle

(Bloomberg) -- Sanofi is working with an adviser to start preparations for a planned separation of its consumer health division, people with knowledge of the matter said.Most Read from BloombergHamas Chief Who Deceived Israel Is Target No. 1 Deep UndergroundBiden, Xi Declare Progress After Concluding Four-Hour SummitXi Says China Seeks to Be Friends With US, Won’t Fight ‘Hot War’Bond Yields Slide on ‘Fed-Friendly’ Economic Data: Markets WrapIsrael Latest: Biden Defends Hospital Raid, Says Hamas

Yahoo | November 16, 2023

Read More 'SNY' Stories Here

SNY Price Returns

1-mo 0.84%
3-mo -12.06%
6-mo -8.41%
1-year 4.59%
3-year -0.94%
5-year 21.96%
YTD -0.94%
2022 -1.00%
2021 5.87%
2020 -0.83%
2019 23.73%
2018 4.20%

SNY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full SNY Dividend History

Continue Researching SNY

Want to see what other sources are saying about Sanofi's financials and stock price? Try the links below:

Sanofi (SNY) Stock Price | Nasdaq
Sanofi (SNY) Stock Quote, History and News - Yahoo Finance
Sanofi (SNY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!